Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
9017298 | Pulmonary Pharmacology & Therapeutics | 2005 | 6 Pages |
Abstract
In this model all treatments except with DSCG caused a significant but small loss of protection against methacholine-induced bronchoconstriction. Thus, tolerance was not prevented by 2 weeks of additional treatment with DSCG, in contrast to in vitro findings.
Related Topics
Health Sciences
Medicine and Dentistry
Pulmonary and Respiratory Medicine
Authors
Frank Kanniess, Rudolf A. Jörres, Helgo Magnussen,